Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
I do not fear death. But like most of us, I fear great suffering.
Elevated levels of a protein called RUNX2 in human lung tumors predict a worse prognosis.
A horned dino is believed to have had osteosarcoma almost 77 million years ago.
I think about my birthday differently ever since my diagnosis of stage IIA invasive lobular breast cancer.
Three days after Thanksgiving, Alex Bartlett ended up in the emergency room with excruciating and debilitating back pain.
Based on animal studies, researchers suggest that beta blockers may help.
One finding of the project was that, on average, the genome of cancer cells contains four or five “driver” mutations.
Last year, the FDA approved three new antibody-drug conjugates for treating cancer.
A new study developed a model categorizing the disease, and a treatment’s likelihood of success, based on the tumor’s site of origin.
The dog’s owner bought the ad to share the good news about his recovery and raise awareness about cancer in dogs.
Researcher interview with Jason Locasale
Scientists are combining immunotherapy agents to try to jump-start the immune system against solid tumors in children.
The study results also suggest that drugs targeting the two subsets could thwart the metastatic process in some cancers.
Better treatments for hepatitis B and C and a lack of such advances for fatty liver or alcoholic liver disease are driving outcomes.
An ongoing study is assessing pediatric and young adult cancers that did not respond to initial treatments.
Researchers are using multiple strategies to tackle the same problem—how to activate T cells in people who don’t respond to immunotherapy.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.